Actual survival after resection of primary colorectal cancer: results from a prospective multicenter study
Open Access
- 5 April 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in World Journal of Surgical Oncology
- Vol. 19 (1), 1-10
- https://doi.org/10.1186/s12957-021-02207-4
Abstract
Colorectal cancer is the third most common type of cancer in the world. We characterize a cohort of patients who survived up to 5 years without recurrence and identify factors predicting the probability of cure. We analyzed data of patients who underwent curative intent surgery for stage I–III CRC between 2007 and 2012 and who had had been included in a large multicenter study in the Netherlands. Cure was defined as 5-year survival without recurrence. Survival data were retrieved from a national registry. Analysis of data of 754 patients revealed a cure rate of 65% (n = 490). Patients with stage I disease and T1- and N0-tumor had the highest probability of cure (94%, 95% and 90%, respectively). Those with a T4-tumor or N2-tumor had the lowest probability of cure (62% and 50%, respectively). A peak in the mortality rate for older patients early in follow-up suggests early excess mortality as an explanation. A similar trend was observed for stage III disease, poor tumor grade, postoperative complications, sarcopenia, and R1 resections. Patients with stage III disease, poor tumor grade, postoperative complications, sarcopenia, and R1 resections show a similar trend for decrease in CSS deaths over time. In the studied cohort, the probability of cure for patients with stage I–III CRC ranged from 50 to 95%. Even though most patients will be cured from CRC with standard therapy, standard therapy is insufficient for those with poor prognostic factors, such as high T- and N-stage and poor differentiation grade.Keywords
This publication has 41 references indexed in Scilit:
- The long-term survival characteristics of a cohort of colorectal cancer patients and baseline variables associated with survival outcomes with or without time-varying effectsBMC Medicine, 2019
- Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer–Specific Mortality in Patients With Stage II or III Colorectal CancerJAMA, 2018
- Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker studyAnnals of Oncology, 2017
- Body Fatness and Cancer — Viewpoint of the IARC Working GroupThe New England Journal of Medicine, 2016
- Weight Change and Risk of Colorectal Cancer: A Systematic Review and Meta-AnalysisAmerican Journal of Epidemiology, 2015
- Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal CancerJAMA, 2014
- Is Diabetes Mellitus an Independent Risk Factor for Colon Cancer and Rectal Cancer?The American Journal of Gastroenterology, 2011
- Cure frailty models for survival data: Application to recurrences for breast cancer and to hospital readmissions for colorectal cancerStatistical Methods in Medical Research, 2011
- Estimating and modeling the cure fraction in population-based cancer survival analysisBiostatistics, 2006
- The preoperative assessment and postoperative surveillance of patients with colon and rectal cancerSurgical Clinics of North America, 2002